SCHEMBL7940833

SCHEMBL7940833

COc1ccc2c(c1)C(=O)N(CI)C2

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 19/20 0.58
TNF P01375 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7943382 0.86 ADAM17 (0.60) ADAM17TNF
SCHEMBL5955654 0.85 ADAM17 (0.58) ADAM17TNF
SCHEMBL8235144 0.85 ADAM17 (0.58) ADAM17TNF
SCHEMBL7945201 0.85 ADAM17 (0.58) ADAM17
SCHEMBL6442206 0.82 ADAM17 (0.56) ADAM17TNF
SCHEMBL25761822 0.81 ADAM17 (0.56) ADAM17
SCHEMBL5955508 0.81 ADAM17 (0.55) ADAM17TNF
SCHEMBL29662743 0.80 ADAM17 (0.55) ADAM17TNF
SCHEMBL20553902 0.80 ADAM17 (0.57) ADAM17
SCHEMBL5956220 0.80 ADAM17 (0.54) ADAM17TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976849-B1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS MERCK SHARP & DOHME (US) 2016-03-09 EP disclosed
EP-1973901-B1 HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS MERCK SHARP & DOHME (US) 2014-12-17 EP disclosed
WO-2010054278-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-05-14 WO disclosed
WO-2007084415-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed